Literature DB >> 17826487

Voided urinary cytology in bladder cancer: is it time to review the indications?

Raghav Talwar1, Tapan Sinha, S C Karan, D Doddamani, A Sandhu, G S Sethi, A Srivastava, V Narang, A Agarwal, N Adhlakha.   

Abstract

OBJECTIVES: The sensitivity of voided urinary cytology has been reported as very low. In this study, we investigated the sensitivity and clinical utility of voided urinary cytology in the detection of various grades and stages of transitional cell carcinoma (TCC) of the bladder compared with the urinary nuclear matrix protein-22 (NMP-22) qualitative assay.
METHODS: From March 2004 to April 2006, all patients with TCC of the bladder receiving follow-up care and those presenting with gross hematuria were enrolled in this prospective study. These patients underwent urinary cytologic examination and NMP-22 qualitative assay. The diagnosis, determined from the cystoscopy findings and biopsy findings of the suspicious lesion, was accepted as the reference standard.
RESULTS: A total of 196 patients were enrolled in this study, of whom 127 patients had previously been diagnosed with bladder TCC and 69 were presenting for investigation of gross hematuria. A total of 52 cases of bladder TCC were diagnosed. The overall sensitivity of voided urine cytology and NMP-22 assay was 21.1% and 67.3%, respectively (P <0.001). The sensitivity of urinary cytology and urinary NMP-22 for well-differentiated tumors was 9.5% and 52.4%, respectively, and was 18.1% and 77.3%, respectively (P <0.001), in moderately differentiated tumors. The overall specificity of urinary cytology for TCC of the bladder was 98.6% and was greater than the specificity of NMP-22 (80.5%).
CONCLUSIONS: The results of our study suggest that urinary cytology has a very low sensitivity and can be omitted in favor of NMP-22 in the follow-up of low-grade superficial bladder TCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826487     DOI: 10.1016/j.urology.2007.03.070

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer.

Authors:  I Sokolov; M E Dokukin; V Kalaparthi; M Miljkovic; A Wang; J D Seigne; P Grivas; E Demidenko
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

Review 2.  Cell-free DNA in blood and urine as a diagnostic tool for bladder cancer: a meta-analysis.

Authors:  Xin-Shuai Wang; Meng-Qi Zhao; Li Zhang; De-Jiu Kong; Xue-Zhen Ding; Xiao-Chen Hu; Jun-Qiang Yang; She-Gan Gao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

3.  [Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].

Authors:  J Hess; S Tschirdewahn; T Szarvas; R Rossi; H Rübben; F Vom Dorp
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

4.  Urine-based assays for the detection of bladder cancer.

Authors:  Patrick Villicana; Bryant Whiting; Steve Goodison; Charles J Rosser
Journal:  Biomark Med       Date:  2009-06-01       Impact factor: 2.851

5.  Methylation markers for urine-based detection of bladder cancer: the next generation of urinary markers for diagnosis and surveillance of bladder cancer.

Authors:  Thomas Reinert
Journal:  Adv Urol       Date:  2012-06-18

Review 6.  Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.

Authors:  Bénédicte Clin; Jean-Claude Pairon
Journal:  BMC Public Health       Date:  2014-11-06       Impact factor: 3.295

7.  Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.

Authors:  Dana Vu Van; Ulrike Heberling; Manfred P Wirth; Susanne Fuessel
Journal:  Oncol Lett       Date:  2016-08-23       Impact factor: 2.967

Review 8.  Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis.

Authors:  Nicolas Adrianto Soputro; Dylan Neil Gracias; Brendan Hermenigildo Dias; Tatenda Nzenza; Helen O'Connell; Kapil Sethi
Journal:  BJUI Compass       Date:  2022-03-28

9.  Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.

Authors:  Angela A G van Tilborg; Lucie C Kompier; Irene Lurkin; Ricardo Poort; Samira El Bouazzaoui; Kirstin van der Keur; Tahlita Zuiverloon; Lars Dyrskjot; Torben F Orntoft; Monique J Roobol; Ellen C Zwarthoff
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

10.  ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis.

Authors:  Houguang He; Conghui Han; Lin Hao; Guanghui Zang
Journal:  Oncol Lett       Date:  2016-05-12       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.